Blog

Mental health disorders like depression, anxiety, PTSD, and chronic pain can be incredibly challenging to treat. While traditional medications such as antidepressants work for many, some individuals struggle to find lasting relief. This is where ketamine therapy has emerged as a groundbreaking treatment option. Ketamine, originally used as an anesthetic,

In recent years, ketamine has emerged as a promising treatment option for mental health disorders, offering hope to those who haven’t found relief with traditional therapies. Once known primarily as an anesthetic, ketamine is now recognized for its unique ability to treat conditions like depression, anxiety, PTSD, and more. If

When it comes to treating depression, particularly treatment-resistant depression (TRD), both Spravato® and ketamine have garnered attention for their innovative approaches. While they share similarities, including their origin and mechanisms of action, there are significant differences between the two. Understanding these distinctions can help patients and providers make informed decisions

Spravato® (esketamine) is a groundbreaking FDA-approved treatment specifically designed for adults with treatment-resistant depression (TRD). Unlike traditional antidepressants that target serotonin or other monoamines, Spravato® offers a novel mechanism of action, providing rapid relief for individuals who haven’t responded to other therapies. Let’s delve into how Spravato® works and why

For those struggling with treatment-resistant depression, choosing the right therapy can be challenging. Spravato® (esketamine nasal spray) has emerged as a novel treatment option, especially for individuals who haven’t responded to traditional antidepressants. Here’s a look at how Spravato® compares to conventional antidepressants in terms of efficacy, onset of action,